Metraipolis › archive › dc_b37bf55aa691

Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy — Europe PMC PMID:41368628

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41368628
DOI
10.3389/fimmu.2025.1691661
License (as archived)
solo-consultazione
Archived
2026-11-08T07:45:13.059Z
SHA-256 of the archived text
6d3c3ea2dd6e574514b8f169e6798d424907add0eb6fcaec9c52af6119330fa5
Stable URL of this page
https://metraipolis.com/documento/dc_b37bf55aa691

How to cite

Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy — Europe PMC PMID:41368628 — Europe PMC (en), https://europepmc.org/article/MED/41368628 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b37bf55aa691 (Metraipolis archive dc_b37bf55aa691, sha256 6d3c3ea2dd6e574514b8f169e6798d424907add0eb6fcaec9c52af6119330fa5)
BibTeX
@misc{dcb37bf55aa691,
  title = {Crosstalk between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and immunotherapy — Europe PMC PMID:41368628},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41368628},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b37bf55aa691; sha256 6d3c3ea2dd6e574514b8f169e6798d424907add0eb6fcaec9c52af6119330fa5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41368628. Agents can read the archived copy with the MCP tool read_document.